Mylan CEO in 2006 Decried Practice It’s Now Using on EpiPen

August 29, 2016 5:35 PM

19 0

Mylan CEO in 2006 Decried Practice It’s Now Using on EpiPen

In 2006, the drugmaker’s chief executive officer Heather Bresch said that “authorized generics” -- like the one her company is now introducing for EpiPen after an outcry over the drug’s price -- were a grave threat to the generic drug industry and hurt consumers.

Bresch, who was Mylan’s vice president of corporate development at the time, asked Congress in July 2006 to curb brand-name drugmakers’ practice of selling unbranded versions of their own medicines to thwart generic competition. She called the strategy “the single greatest threat to the generic indu...

Also read: Trump warns Wall Street: I'm going to cut drug prices

Read more

To category page

Loading...